Ramirez Asset Management
GILD icon

Ramirez Asset Management’s Gilead Sciences GILD Stock Holding History

Ramirez Asset Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,558
Closed -$369K – 395
2023
Q4 		$369K Hold
4,558
– – 0.07% 181
2023
Q3 		$342K Buy
+4,558
New +$351K 0.07% 189

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ramirez Asset Management's GILD Position: Q1 2024 in Review

Ramirez Asset Management sold out of Gilead Sciences (GILD) in Q1 2024, closing a stake of 4,558 shares — an estimated $369K sold.

Ramirez Asset Management first reported a position in GILD in Q3 2023 and held it in 2 quarters. The position peaked at $369K in Q4 2023. 1,724 funds tracked by Wall St. Rank hold GILD as of Q1 2024.

  • Ramirez Asset Management reported no remaining Gilead Sciences position as of Q1 2024 after selling out during the quarter.
  • Ramirez Asset Management sold 4,558 Gilead Sciences shares in Q1 2024, an estimated $369K.
  • Ramirez Asset Management first reported a position in Gilead Sciences in Q3 2023 and held it in 2 quarters.
  • Ramirez Asset Management's Gilead Sciences position peaked at $369K in Q4 2023.
  • 1,724 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2024.

Based on Ramirez Asset Management's 13F filing for Q1 2024, filed 14 May 2024.